NTLA-2001
Intellia Therapeutics
['cardio', 'crispr']
ntla-2001, a crispr-based genomic therapy, lowered serum ttr in patients with attr-cm by more than 90% #aha22 #cardiotwitter #cardiology 
The content you need, when you need it.